Privium Fund Management (UK) Ltd - BOLT BIOTHERAPEUTICS INC ownership

BOLT BIOTHERAPEUTICS INC's ticker is BOLT and the CUSIP is 097702104. A total of 36 filers reported holding BOLT BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Privium Fund Management (UK) Ltd ownership history of BOLT BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$121,177
-18.1%
116,5160.0%0.10%
-18.8%
Q2 2023$147,975
-1.6%
116,5160.0%0.12%
-0.8%
Q1 2023$150,306
-0.8%
116,5160.0%0.12%
+2.6%
Q4 2022$151,471
-11.9%
116,5160.0%0.12%
-47.5%
Q3 2022$172,000116,5160.22%
Other shareholders
BOLT BIOTHERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 1,891,467$5,183,0002.45%
Nan Fung Group Holdings Ltd 1,166,952$3,197,0001.52%
Vivo Capital, LLC 3,871,291$10,607,0000.73%
Samsara BioCapital, LLC 1,049,153$2,875,0000.72%
Novo Holdings A/S 4,503,991$12,341,0000.65%
Sofinnova Investments, Inc. 2,754,437$7,547,0000.57%
Hawkeye Capital Management, LLC 415,039$1,137,0000.45%
SUVRETTA CAPITAL MANAGEMENT, LLC 2,230,250$6,111,0000.19%
Board of Trustees of The Leland Stanford Junior University 719,546$1,972,0000.11%
Echo Street Capital Management LLC 123,804$5,493,0000.04%
View complete list of BOLT BIOTHERAPEUTICS INC shareholders